PPH
ETF
Pharmaceuticals
NYSEARCA
VanEck Pharmaceutical ETF
$111.19
+0.89 (+0.81%)
Fund Overview
by VanEck
Tracks large-cap pharmaceutical companies globally, including both U.S. and international big pharma names like Novo Nordisk, AstraZeneca, and Roche.
AUM$540M
Expense Ratio0.36%
Holdings25
Dividend Yield1.8%
DistributionQuarterly
BenchmarkMVIS US Listed Pharmaceutical 25 Index
InceptionDec 2011
ExchangeNYSEARCA
Price Data
Open$110.79
Prev Close$110.30
Day Range$110.57 — $111.96
Investment Calculator
See how much dividend income PPH could generate based on its current price of $111.19 and 1.8% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,895.91
Annual Income$178.13
Monthly Income$14.84
Based on current dividend yield of 1.8%. Actual distributions may vary. Past dividends do not guarantee future payments.
Pharmaceuticals ETF Comparison
| ETF | Price | Change | Expense | AUM | Holdings | Yield |
|---|---|---|---|---|---|---|
| PPH | $111.19 | +0.81% | 0.36% | $540M | 25 | 1.8% |
| IHE | $90.42 | +0.36% | 0.40% | $680M | 42 | 1.4% |
Top Pharmaceuticals Stocks
View all →
PPH FAQ
What is PPH?
PPH is the VanEck Pharmaceutical ETF, an exchange-traded fund managed by VanEck. It tracks the MVIS US Listed Pharmaceutical 25 Index and holds 25 Pharmaceuticals securities with an expense ratio of 0.36%.
What is the expense ratio of PPH?
PPH charges an annual expense ratio of 0.36%, which means you pay $36.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does PPH pay dividends?
Yes, PPH pays a 1.8% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $180.00 per year in dividend income.
What are the alternatives to PPH?
Other pharmaceuticals ETFs include IHE. Each offers different expense ratios, weighting methodologies, and number of holdings. Compare them in the ETF comparison table above to find the best fit for your portfolio.
Explore Pharmaceuticals Stocks
View our full list of individual pharmaceuticals stocks with prices, fundamentals, and analyst ratings.
Last updated: Feb 15, 2026 at 1:19 AM ET